Bioactive Compounds
-
B7046 A-71623Summary: CCK1 agonist -
B7191 O-1602Summary: GPR55 cannabinoid receptor agonist -
B7239 SarcosineSummary: Endogenous inhibitor of GlyT1 -
B7316 SwainsonineSummary: Inhibitor of α-mannosidase II which inhibits glycoprotein processing -
B7407 Insulin (human) recombinant expressed in yeastTarget: Insulin ReceptorsSummary: Endogenous insulin receptor agonist -
B7463 RF 9Summary: neuropeptide FF receptors antagonist -
B7699 BorrelidinSummary: threonyl-tRNA synthetase (ThrRS) inhibitor -
B7775 L-Glutathione ReducedSummary: An endogenous antioxidant -
B5052 Nocistatin (bovine)Summary: endogenous peptide used to block nociceptin-induced allodynia and hyperalgesia -
B5134 L-R4W2Summary: Vanilloid TRPV1 (VR1) receptor antagonist peptide

